ABSTRACT AIM: 11β hydroxysteroid dehydrogenase (11β HSD) catalyzes the interconversion of glucocorticoids to inert metabolites in man and rodents and plays a crucial role in regulating corticosteroid hormone action. The physiological role and regulation of 11β HSD type 2 in the adrenal gland remains obscure. Therefore, the aim of the present study was to establish the pattern of 11β HSD type 2 expression in rat adrenal gland under conditions of testosterone withdrawal. MATERIAL AND METHODS: We performed immunohistochemical analyses of adrenal gland sections of ethane dimethanesulphonate (EDS)-treated adult rats. RESULTS: In controls, strong positive 11β HSD type 2 signals were detected in the adrenal cortex cells, but not in the medulla. We observed the lowest 11β HSD type 2 expression intensity 7 days after initial treatment with ethane dimethanesulphonate (EDS) followed by progressive increase in the immunoreactivity toward days 14 and 21. Maximal staining intensity of 11β HSD type 2 in the adrenocorticocytes was found by day 35 after EDS treatment. CONCLUSIONS: By using the EDS model the present study provides new data about 11β HSD type 2 expression in the adrenal gland under conditions of testosterone withdrawal of adult rats. Our results elucidate further the functional signifi cance of 11β HSD system in rat adrenal gland and the regulatory role of testosterone in its activity.
INTRODUCTION
Recently, it has been reported that ethane dimethanesulphonate (EDS), a specifi c toxicant for Leydig cells in testis, has a strong deleterious effect on steroidogenic cells of adult male rat adrenal cortex. EDS administration produced drastic decrease in adrenal weight and morphometric analysis revealed atrophy in all adrenocortical zones. The changes were most prominent in the inner zones -zona fasciculata and zona reticularis. 1 11β hydroxysteroid dehydrogenase (11β HSD) catalyzes the interconversion of biologically active cortisol to cortisone in man and cotricosterone to 11-dehydrocorticosterone in rodents and plays a crucial role in regulating corticosteroid hormone action. 2 Inhibition of 11β HSD allows access of cortisol or corticosterone to the mineralcorticoid receptors where it acts as a mineralcorticoid. 3 Two kinetically distinct forms of this enzyme have been characterized in both man and rodents: a low affi nity NADP(H)-dependent oxoreductase 11β HSD type 1 (11β HSD1) and a high-affi nity uni-directional NAD+-dependent dehydrogenase 11β HSD type 2 (11β HSD2). 4 Northern blot analyses revealed expression of mRNA species encoding both 11β HSD1 and 11β HSD2 in the whole rat adrenal gland. In situ hybridization of rat adrenal cortex and medulla revealed specifi c localization of 11β HSD1 mRNA predominantly to cells at the corticomedullary junction, within the inner cortex, suggesting that the oxoreductase enzyme may serve to maintain high medullary glucocorticoid concentrations required for catecholamine biosynthesis. In contrast, 11β HSD2 mRNA was more uniformly distributed in cortex and was low/absent in the medulla. 5, 6 The physiological role and regulation of 11β HSD2 in the adrenal gland remains obscure. Therefore, the aim of the present study was to establish the pattern of 11β HSD type 2 expression in adrenal gland under conditions of testosterone withdrawal in treated with EDS adult rats. 
MATERIAL AND METHODS
Adrenal glands obtained from male mature Wistar rats that received single intraperitoneal injection of EDS at a dose of 75 mg/kg body weight dissolved in dimethyl sulfoxide (DMSO) and water (1:3, v/v) were used as material. A control group of rats received a single i.p. injection only of DMSO:water. The animals were killed on days 1, 7, 14, 21 and 35 after initial treatment (n = 10 per group). Adrenal gland fragments approximately 4-5 mm thick were fi xed by immersion in Bouin's fl uid for 24 hours at room temperature, embedded in paraffi n and prepared for routine histological examination (staining with hematoxylin-eosin) and immunohistochemistry. Sections (6 μm thick) were mounted on chromegelatin precoated slides. After incubation with 1.2% H 2 O 2 in absolute methanol to inhibit endogenous peroxidase activity, the sections were treated with 2.0% normal rabbit serum (NRS, Sigma, Germany) to block non-specifi c binding sites. As next step, the sections were incubated for 24 hours at 4°C in a humid chamber with the primary polyclonal sheep anti-11βHSD type 2 antibody (Chemicon, USA; 1:1000), kindly provided by Prof. M. Davidoff (University of Hamburg, Germany). For visualization of the antigen-antibody reaction the avidin-biotinperoxidase complex (ABC) method with a Vectastain Elite ABC kit (Vector Lab, USA) was applied. The peroxidase activity was then developed by means of 3, 3'-diaminobenzidine tetra-hydrochloride (DAB) chromogene substrate kit, (Vector, USA).
As controls, sections were used in which the primary, secondary or tertiary antibodies were replaced by phosphate-buffered saline (PBS) and only the peroxidase activity was visualized.
All experimental procedures were approved by the Ethical Committee of the Medical University Plovdiv, Bulgaria (№2/21.11.2007 ).
RESULTS
Our routine histological and immunohistochemical analyses revealed atrophy of all adrenocortical zones after exposure with EDS of adult male rats. The changes were most prominent in the inner zones of rat adrenal glands -zona fasciculata and zona reticularis (Fig. 1) .
In control animals strong intensity of 11β HSD type 2 immunoreactivity was detected in the cytoplasm of adrenocorticocytes in the zona fasciculata and zona reticularis, but not in the medulla. Positive signals with weaker intensity were found in the adrenocorticocytes of zona glomerulosa. The adipocytes of adrenal adipose capsule showed also 11β HSD2 immunoreactivity (Figs. 2a, 2b ). Using EDS model of adult rats we observed the lowest 11 βHSD2 expression intensity 7 days after initial treatment followed by progressive increase in the immunoreactivity toward days 14 and 21. Maximal staining intensity of 11β HSD2 in the adrenocorticocytes was detected by day 35 after EDS treatment. No remarkable changes in 11βHSD2 immunoreactivity were found in the adipocytes of capsula adiposa following EDS administration (Figs. 2c-f ).
DISCUSSION
The expression of 11β HSD2 has been demonstrated in rat adrenal gland by immunohistochemical and The ubiquitous presence of 11β HSD2 in sodiumtransporting epithelia revealed that mineralcorticosteroid action is facilitated by this enzyme which metabolizes glucocorticoids and allows aldosterone to bind to the nonselective mineralcorticoid receptor. 7 In the present study rat adrenal gland showed evidence of the 11β HSD2-immunoreactivity in the zona fasciculata and zona reticularis, but not in the medulla. Less sensitive were the adrenocorticocytes of zona glomerulosa. Our data are in Control group (a, b) . 11β HSD2-immunoreactivity in the zona fasciculata (ZF) and zona reticularis (ZR). Less sensitive were the adrenocorticocytes of zona glomerulosa (ZG) . No positive signals in the medulla (M). Immunoreactive 11β HSD2 was found also in the adipocytes of adrenal capsula adiposa (A). 7 days after EDS (c, d). Lower staining intensity for 11β HSD2 in the adrenal cortex. 21 days after EDS (e, f). Immunoreactivity for 11β HSD2 increased in the adrenocorticocytes of zona fasciculata and zona rericularis. ×200. concordance with previous reports demonstrating that 11β HSD2 mRNA was more abundant in cortex versus medulla, and that rat adrenal glands showed evidence of the 11 beta HSD2 antigen in the zona fasciculata and zona reticularis, but not in the zona glomerulosa or medulla. 6, 7 Also, the adipocytes of adrenal adipose capsule were 11β HSD2 positive suggesting the prereceptor or intracrine regulatory role of this enzyme in the tissue-specifi c availability of active glucocorticoids. 8 Our routine histological and immunohistochemical analysis revealed atrophy of all adrenocortical zones, whereas the changes were most prominent in the inner zones. The current data are consistent with previous studies regarding the deleterious effect of EDS on steroidogenic cells of adult male rat adrenal cortex. 1 Using model of EDS treated rats we have found that the dynamic of 11β HSD2 expression correlated with the changes of serum testosterone levels following the exposure with EDS. 9 The lowest 11 βHSD2 staining intensity was found 7 days after EDS followed by progressive increase in the immunoreactivity toward days 14 and 21. Moreover, the observed restoration of 11β HSD2 activity on day 14 after EDS corresponded with unchanged glandular and serum corticosterone levels in treated rats on day 15 reported by Plećas et al. 10 The immunoreactivity for 11βHSD2 in the adipocytes of adrenal capsula adiposa after EDS treatment appears to be unchanged and the functional role of this enzyme in adipocyte biology remains to be elucidated.
Enzymatic assays on tissue homogenates showed extensive conversion of corticosterone to its 11-dehydro product in an NAD+-dependent manner in adrenal gland. 7 In our previous study 11 , a strong reduction in the activity of NADH 2 -cytochrome-C-reductase that is involved in NAD synthesis as a cofactor was found by enzymehistochemistry in the adrenal gland after EDS treatment of mature rats.
Our immunohistochemical analysis revealed that the 11β HSD2 expression pattern in adrenal gland of EDS treated rats is very similar to that of NADH 2 -cytochrome-C-reductase. The present fi ndings support the view that 11β HSD2 acts as a high-affi nity NAD+-dependent dehydrogenase in the rat adrenal gland. 7 On the other hand, the observed increase in the expression intensity of 11β HSD2 as well as of NADH2 cytochromе-Creductase 11 in rat adrenal gland on day 14 after EDS treatment coincided with the appearance of the repopulation of testosterone-producing Leydig cells in testis. 12 These data pointed out the role of the gonadal steroids, especially of testosterone like the modulators of the adrenal gland functional activity. The above mentioned statement is consistent with previously reported results related to the direct impact of testosterone on the key steps in the adrenal gland steroidogenesis. 13 The present fi ndings identifi ed 11β HSD2, a high-affi nity NAD+-dependent uni-directional dehydrogenase, as a site of action of testosterone in rat adrenal cortex. By using EDS experimental model the present study provides new data about expression of 11β HSD2 in adrenal gland under conditions of testosterone withdrawal. Our results bring additional elucidation on the functional signifi cance of 11β HSD system in rat adrenal gland and the regulatory role of testosterone in its activity. Together with our previous studies 9, 12 , the current data indicate the relationship between 11β HSD2 expression in adrenal gland and kinetics of restoration of testosterone production during renewal of Leydig cell population in testis after EDS treatment.
